link.springer.com

Failure of carbamazepine to prevent clonazepam withdrawal status epilepticus - Neurological Sciences

  • ️Rosati, G.
  • ️Sat Sep 01 1984

Abstract

We describe two patients in whom clonazepam withdrawal status epilepticus occurred in spite of therapeutic levels of carbamazepine in plasma and cere-brospinal fluid. The failure of carbamazepine to prevent clonazepam withdrawal status epilepticus is discussed.

Sommario

Gli autori riportano due casi di stato di male epilettico da sospensione di clonazepam nonostante i livelli terapeutici di carbamazina nel plasma e nel liquor. La mancanza di efficacia della carbamazepina nel prevenire lo stato di male epilettico da sospensione di clonazepam viene discussa.

Access this article

Log in via an institution

Subscribe and save

  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bastie Y.:Depakine in the prevention of epileptic attacks during alcohol withdrawal. Ann Med Psychol 128: 400–404, 1970.

    Google Scholar 

  2. Bjorquist SE, Isohanni M., Makela R. et al.:Ambulant treatment of alcohol withdrawal symptoms with carbamazepine: A formal multicentre double-blind comparison with placebo. Acta Psychiatric Scand 53: 333–342, 1976.

    Google Scholar 

  3. Cavazzutti G.B.:Prevention of febrile convulsions with dipropylacetate (Depakine). Epilepsia 16: 647–648, 1975.

    PubMed  Google Scholar 

  4. Chu N-S.:Carbamazepine: Prevention of alcohol withdrawal seizures. Neurology 29: 1397–1401, 1979.

    PubMed  Google Scholar 

  5. Edwards V.E.:Side effects of clonazepam therapy Proc Aust Assoc Neurol ii: 199–202, 1974.

    Google Scholar 

  6. Hillbom M.E.:The prevention of ethanol withdrawal seizures in rats by dipropylacetate. Neuropharmacology 14: 755–761, 1975.

    PubMed  Google Scholar 

  7. Johannessen SI, Gerna M., Bakke J. et al.:CSF concentrations and serum protein binding of carbamazepine and carbamazepine 10, 11-epoxide in epileptic patients. Br J Clin Pharmacol 3: 575–582, 1976.

    Google Scholar 

  8. Knop H.J., Van Der Kleijn E., andEdmunds L.C.:Pharmacokinetics of clonazepam in man and laboratory animals. In: Schneider H., Janz D., Gardner-Thorpe C., Meinardi H., Sherwin A.L. (Eds), Clinical Pharmacology of Antiepileptic Drugs, Springer-Verlag, Berlin-Heidelberg, pp 247–260, 1975.

    Google Scholar 

  9. Lockard J.S., Levy R.H., Congdon W.C. et al.:Clonazepam in focal-motor monkey model: Efficacy, tolerance, toxicity, withdrawal and management. Epilepsia 20: 683–695, 1979.

    PubMed  Google Scholar 

  10. Monaco F., Sechi G.P., Mutani R. et al.:Lack of efficacy of carbamazepine in preventing the recurrence of febrile convulsions.In: Johannessen S.I., Morselli P.L., Pippenger C.E., Richens A., Schmidt D. and Meinardi H. (Eds), Antiepileptic Therapy: Advances in Drug Monitoring, Raven Press, New York, pp 75–79, 1980.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinica Neurologica, Università di Sassari, Italia

    Sechi G. P., Zoroddu G. & Rosati G.

Authors

  1. Sechi G. P.

    You can also search for this author in PubMed Google Scholar

  2. Zoroddu G.

    You can also search for this author in PubMed Google Scholar

  3. Rosati G.

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Sechi, G.P., Zoroddu, G. & Rosati, G. Failure of carbamazepine to prevent clonazepam withdrawal status epilepticus. Ital J Neuro Sci 5, 285–287 (1984). https://doi.org/10.1007/BF02043959

Download citation

  • Issue Date: September 1984

  • DOI: https://doi.org/10.1007/BF02043959

Key-words